Burchardt U, Franke M, Krauss J, Barth A
Z Urol Nephrol. 1986 Oct;79(10):587-93.
The course of the excretion of dipeptidyl-peptidase IV (DP IV)-alanine aminopeptidase, beta-glucuronidase and total protein with the urine was investigated during the treatment of 11 patients with pyelonephritis with gentamicin, after application of a renal radiographic contrast medium in 7 patients with arterial hypertension and after regional perfusion of an extremity in 10 patients with malignant melanoma. In the reference group in male test persons with 147.0 nmol/s X l a higher DP IV activity in the urine was recognized than in the female test persons (100.0 nmol/s X l). After application of the drugs a rhythmically intermitting increased excretion of all enzymes mentioned develops. The study confirms the usuability of the DP IV-activity for enzymological investigations of the urine.
在11例肾盂肾炎患者用庆大霉素治疗期间、7例动脉高血压患者应用肾脏造影剂后以及10例恶性黑色素瘤患者肢体区域灌注后,对尿中二肽基肽酶IV(DP IV)-丙氨酸氨基肽酶、β-葡萄糖醛酸酶和总蛋白的排泄过程进行了研究。在参考组中,男性测试者尿液中DP IV活性为147.0 nmol/s·L,高于女性测试者(100.0 nmol/s·L)。用药后,上述所有酶的排泄出现有节律的间歇性增加。该研究证实了DP IV活性在尿液酶学研究中的可用性。